南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停南美超级胎牛血清999尝鲜特惠转染试剂低至5折基质胶阶梯特惠积分商城,好礼送不停

DNA四面体联合亲和磁悬浮选择性捕获检测循环肿瘤细胞新方法

Integrating DNA tetrahedron with affinity magnetic levitation for selective capture and sensitive detection of circulating tumor cells

Zilong Zhang, Sidi Cun, Yuxuan Yuan, Yujin Lin, Yitao Cao, Yinzi Chen, Jing Zhang, Jing Wang, Xinfeng Zhao

Journal:ANALYTICA CHIMICA ACTA

IF:6.1

DOI:10.1016/j.aca.2026.345493

PMID:

Published:2026-04-07

research field:肿瘤学液体活检生物传感器纳米生物技术分子诊断

Abstract

Circulating tumor cell (CTC) is an evidenced biomarker for early cancer diagnosis and assessment of treatment response. This necessitates increasing attempt to develop new method for detection of CTCs with highly enriching and anti-interference capacity. Herein, we built a simple platform for CTC detection by combining aptamer-mediated specific recognition with affinity magnetic levitation (Maglev). The method involved modification of DNA tetrahedron (TDN) using SYL3C aptamer as tentacles, assembly of aptamer conjugated-TDN on microsphere by azide-alkyne click chemistry, enrichment of CTCs by the activated microspheres, and detection of CTCs by affinity Maglev. These yielded an aptamer sensor resembling octopus tentacles to enhance the capture selectivity and efficiency of CTCs. Once CTCs were captured, a microsphere@TDN@CTCs complex was formed, resulting in a change in the overall density. The number of CTCs was calculated by measuring the levitation height difference between microspheres pro- and post-binding of CTCs in affinity Maglev. An example study on MCF-7 cells exhibited a detection of 8.81 cells mL −1 in buffer solution, with repeatability characterized by a relative standard deviation of less than 4.48%, in comparison to 9.08 cell mL −1 in mimic clinical sample with a relative standard deviation of 6.98%. Analysis of mimic clinical samples demonstrated that the method was effective for the specific detection of CTCs with robust resistance to interference from co-existing substances in plasma. It is possible to serve as an early diagnostic alternative for clinically relevant cancers once large number of clinical trials are performed.

本文使用的Yeasen产品

购物车
客服
转染试用